New York, New York (PRWEB) June 16, 2013
The nationwide law firm of Bernstein Liebhard LLP is investigating diabetes drug lawsuits on behalf of individuals treated with Byetta, Januvia, Victoza and other medications recognized as incretin mimetics, and who have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer. Type II diabetics who had been treated with an incretin mimetic and who have been diagnosed with a single of these illnesses may be entitled to compensation for health-related bills, lost wages, discomfort and suffering and other damages. Medicines integrated in the Firms diabetes drug lawsuit investigation incorporate: